Epizyme Stock Price (NASDAQ:EPZM)

Add to My Stocks
$10.25 $0.2 (1.91%) EPZM stock closing price Sep 21, 2018 (Closing)
Prev Close* : $10.45
Market Cap:
Day Low: $10.05
52 Week Low: $8.61
Open: $10.4
Volume: -
Day High: $10.7
52 Week High: $21.40

Latest Stock Market News

Latest Articles

Epizyme News - From Partners

EPZM Stockcharts

View EPZM PE ratio, PS ratio stocks charts and compare with peers.
EPZM Chart
Note: Compare Epizyme stock price history with the index and industry peers.

Epizyme Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Epizyme Returns

(return on equity)

Epizyme Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

EPZM Industry Peers

Company Price Change (%)
Nightstar Therp (NITE)25.52.28 (8.21%)
Proqr Therapeutics (PRQR)20.20.35 (1.76%)
Stemline Therapeutics (STML)17.30.3 (1.76%)
Kura Oncology (KURA)17.10.1 (0.59%)
Pfizer (PFE)44.060.31 (0.71%)
Merck (MRK)71.10.32 (0.45%)
Novartis (NVS)85.460.51 (0.59%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Novavax (NVAX)1.60.13 (8.84%)
BioDelivery Sciences (BDSI)2.850.15 (5.56%)
Acadia Pharma (ACAD)20.171.06 (5.55%)
Trevena (TRVN)1.720.08 (4.88%)
ELOXX PHARMACT (ELOX)16.040.74 (4.84%)
Paratek Pharma (PRTK)9.650.4 (4.32%)
Athersys (ATHX)1.940.08 (4.3%)
Top gainers from Medical-Biomed-Genetics industry
* As of Sep 21, 2018
CompanyPriceChange (%)
GTx (GTXI)1.821.49 (92.27%)
Uniquire (QURE)38.462.68 (6.51%)
Retrophin (RTRX)27.821.72 (5.82%)
Enzo Biochem (ENZ)4.090.25 (5.76%)
Dicerna Pharma (DRNA)15.990.81 (4.82%)
Innoviva (INVA)14.950.75 (4.78%)
Agenus (AGEN)20.1 (4.76%)
Top losers from Medical-Biomed-Genetics industry
* As of Sep 21, 2018

Epizyme Inc Stock News - Partner Headlines

Epizyme Financial Statements

income statement20172016201520142013
Net Sales or Revenues10M8M2.56M41.41M68.48M
Net Income-134.3M-110.21M-132.37M-55M-3.48M
Total Operating Expense146.84M119.83M135.1M96.45M71.6M
View Epizyme income statement
balance sheet20172016201520142013
Total Assets289.35M252.44M217.9M199.2M162.98M
Total Liabilities53.98M50.74M48.37M38.92M58.67M
Shareholders Equity235.37M201.7M169.53M160.28M104.31M
View Epizyme balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-1.73M8.15M12.03M-53.77M
Net Cash from (used by) Operating Activities-120.43M-96.37M-72.92M-35.36M-53.73M
Increase (Decrease) in Prop Plant And Equipment-0.98M-0.62M-0.18M-2.21M-0.63M
View Epizyme cash flow statement

Epizyme Stock Message Board

Epizyme stock price ended the last trading day at $10.25. The total market value as denoted by $726.31M for Epizyme, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform Epizyme valuation, even though in the short-term, sentiment and current breaking news might affect Epizyme stock price.

Demand for a stock decides its stock market price. For example, if more investors want to buy EPZM stock than sell it, then Epizyme stock price goes up. Conversely, if more investors wanted to sell EPZM stock than buy it, there would be greater supply than demand, and the stock price would fall. 583,316 EPZM shares were traded yesterday, and Epizyme stock chart shows that the EPZM stock quote hit a day high of $10.7 and day low of $10.05. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Epizyme does not pay dividends. One can observe stock price trends and check for volatility by checking Epizyme stock price history.